MedTrace Logo

Blood Volume Analysis and Related Outcomes in Hemodialysis

NCT01679249 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2012-09-10

No results posted yet for this study

Summary

An understanding of fluid changes that occur during hemodialysis (HD) with ultrafiltration (UF) is essential for determining the efficacy of HD, as well as for reducing complications related to hypovolemia or, conversely, chronic volume overload.

Conditions

Sponsors & Collaborators

  • Daxor Corporation

    collaborator INDUSTRY

  • VA New York Harbor Healthcare System

    lead FED

Principal Investigators

  • David S Goldfarb, MD · VA New York Harbor Healthcare System

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01679249 on ClinicalTrials.gov